Association of VA Medication Copayment Restructuring With Pharmacy Use,Medication Costs,and Financial Burden of Medications

Abstract

In February 2017, the Department of Veterans Affairs (VA) restructured outpatient medication copayments, creating three medication tiers comparable with private-sector value-based insurance designs (with copayments: US$5, US$8, US$11 per 30-day supply for Tiers 1–3, respectively); however, Veteran medication management experiences have not been assessed following this change. We invited a random sample of Veterans with chronic conditions (e.g., diabetes, hypertension) who utilized VA services to complete a mailed survey about VA and non-VA pharmacy use and medication management experiences following this restructuring. There were 2,884 respondents (29% response rate). Veterans with the lowest proportion of medications from Tier 1 after the restructuring had the highest predicted probability of non-VA pharmacy use from regression analyses. Among respondents subject to VA copayments, 27% reported being better able to afford medications after the restructuring. However, 29% reported worrying about paying for medications, and 18% reported making tradeoffs (e.g., spending less on utilities, food) to pay for prescriptions.

Keywords

Veterans Affairs copayments medications health policy

Get full access to this article

View all access options for this article.

References

Bradley

E. H.

Curry

L. A.

Devers

K. J.

(2007). Qualitative data analysis for health services research: Developing taxonomy, themes, and theory. Health Services Research, 42(4), 1758–1772.

Callahan

C. M.

Unverzagt

F. W.

Hui

S. L.

Perkins

A. J.

Hendrie

H. C.

(2002). Six-item screener to identify cognitive impairment among potential subjects for clinical research. Medical Care, 40(9), 771–781.

Centers for Medicare & Medicaid Services. (2016, August 10). Medicare advantage value-based insurance design model. https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-value-based-insurance-design-model

Centers for Medicare & Medicaid Services. (2025). Chronic condition warehouse. https://www2.ccwdata.org/web/guest/condition-categories

Chernew

M. E.

Rosen

A. B.

Fendrick

A. M.

(2007). Value-based insurance design. Health Affairs (Project Hope), 26(2), w195–w203.

Creswell

J. W.

Plano Clark

V. L.

(2011). Designing and conducting mixed methods research (2nd ed.). Sage.

Dillman

D. A.

(2000). Mail and internet surveys: The tailored design methods (2nd ed.). John Wiley.

Doshi

J. A.

Zhu

Lee

B. Y.

Kimmel

S. E.

Volpp

K. G.

(2009). Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation, 119(3), 390–397.

Federal Register (2016, January 5). Department of Veterans Affairs. 38 CFR Part 17. RIN 2900-AP35. Copayments for Medications Beginning January 1, 2017 [FR Doc No: 2015-33052]. Proposed Rules, 81(2), 196–204. https://www.govinfo.gov/content/pkg/FR-2016-01-05/pdf/2015-33052.pdf

10.

Fendrick

A. M.

Oesterle

S. L.

Lee

H. M.

Padaley

Eagle

Montagano

(2016, August). Incorporating value-based insurance design to improve chronic disease management in the Medicare advantage program. University of Michigan Center for Value-Based Insurance Design. https://vbidcenter.org/wp-content/uploads/2016/08/MA-White-Paper_final-8-16-16.pdf

11.

Fendrick

A. M.

Smith

D. G.

Chernew

M. E.

(2010). Applying value-based insurance design to low-value health services. Health Affairs (Project Hope), 29(11), 2017–2021.

12.

Fetters

M. D.

Curry

L. A.

Creswell

J. W.

(2013). Achieving integration in mixed methods designs-principles and practices. Health Services Research, 48(6, Pt. 2), 2134–2156.

13.

Frank

M. B.

Fendrick

A. M.

Zbrozek

Holtz

Chernew

M. E.

(2012). The effect of a large regional health plan’s value-based insurance design program on statin use. Medical Care, 50(11), 934–939.

14.

Goldman

D. P.

Joyce

G. F.

Zheng

(2007). Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. Journal of the American Medical Association, 298(1), 61–69.

15.

Haley

Kenney

G. M.

(2012). Uninsured veterans and family members: Who are they and where do they live? (Timely Analysis of Immediate Health Policy Issues). Urban Institute. https://www.urban.org/research/publication/uninsured-veterans-and-family-members-who-are-they-and-where-do-they-live

16.

Hirth

R. A.

Cliff

E. Q.

Gibson

T. B.

McKellar

M. R.

Fendrick

A. M.

(2016). Connecticut’s value-based insurance plan increased the use of targeted services and medication adherence. Health Affairs (Project Hope), 35(4), 637–646.

17.

Hynes

Koelling

Stroupe

Arnold

Mallin

Kok

(2007). Veterans’ access to and use of Medicare and Veterans Affairs health care. Medical Care, 45(3), 214–223.

18.

Kizer

K. W.

(2012). Veterans and the affordable care act. Journal of the American Medical Association, 307(8), 789–790.

19.

Lee

J. L.

Maciejewski

Raju

Shrank

W. H.

Choudhry

N. K.

(2013). Value-based insurance design: Quality improvement but no cost savings. Health Affairs (Project Hope), 32(7), 1251–1257.

20.

Lieberman

D. A.

Polinski

J. M.

Choudhry

N. K.

Avorn

Fischer

M. A.

(2014). Unintended consequences of a Medicaid prescription copayment policy. Medical Care, 52(5), 422–427.

21.

Linden

(2020). COVBAL: Stata module for producing covariate balance statistics. Statistical Software Components, Boston College Department of Economics. https://econpapers.repec.org/software/bocbocode/s458188.htm

22.

Look

K. A.

(2015). Value-based insurance design and medication adherence: Opportunities and challenges. The American Journal of Managed Care, 21(1), e78–e90.

23.

Mann

B. S.

Barnieh

Tang

Campbell

D. J.

Clement

Manns

B. J.

(2014). Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: A systematic review. PLOS ONE, 9(3), Article e89168.

24.

Norton

E. C.

Dowd

B. E.

Garrido

M. M.

Maciejewski

M. L.

(2024). Requiem for odds ratios. Health Services Research, 59(4), Article e14337.

25.

Piette

J. D.

Heisler

Horne

Caleb Alexander

(2006). A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures. Social Science & Medicine, 62(4), 846–857.

26.

Stroupe

K. T.

Smith

B. M.

Hogan

T. P.

St Andre

J. R.

Gellad

W. F.

Weaver

F. M.

(2013). Medication acquisition across systems of care and patient-provider communication among older veterans. American Journal of Health-system Pharmacy, 70(9), 804–813.

27.

Stroupe

K. T.

Smith

B. M.

Lee

T. A.

Tarlov

Durazo-Arvizu

Weiss

K. B.

(2007). Effect of increased copayments on pharmacy use in the Department of Veterans Affairs. Medical Care, 45(11), 1090–1097.

28.

Sullivan

S. D.

Yeung

Vogeler

Ramsey

S. D.

Wong

Watkins

J. B.

(2015). Design, implementation, and first-year outcomes of a value-based drug formulary. Journal of Managed Care & Specialty Pharmacy, 21(4), 269–275.

29.

Trivedi

A. N.

Moloo

Mor

(2010). Increased ambulatory care copayments and hospitalizations among the elderly. The New England Journal of Medicine, 362(4), 320–328.

30.

Veterans Health Adminstration. (2025, January 20). https://www.va.gov/health/aboutVHA.asp

31.

Wang

Liu

C. F.

Bryson

C. L.

Sharp

N. D.

Maciejewski

M. L.

(2011). Does medication adherence following a copayment increase differ by disease burden? Health Services Research, 46(6pt1), 1963–1985.

32.

Wharam

J. F.

Argetsinger

Lakoma

Zhang

Ross-Degnan

(2024). Acute diabetes complications after transition to a value-based medication benefit. JAMA Health Forum, 5(2), Article e235309.